Kleine-Levin Syndrome

Kleine-Levin syndrome, often shortened to KLS, is a rare neurological sleep disorder marked by repeated episodes of extreme sleepiness and long sleep duration. During an episode, a person may sleep most of the day and night, wake only briefly, and experience changes in thinking, mood, perception, eating, or behavior.

KLS can be confusing and distressing because symptoms come in cycles. Between episodes, many people return close to their usual level of alertness, sleep, mood, and functioning. This on-off pattern can make KLS difficult to recognize, especially in teens and young adults, where symptoms may be mistaken for behavioral problems, depression, bipolar disorder, substance use, another sleep disorder, or a neurological condition.

Kleine-Levin syndrome is classified as a central disorder of hypersomnolence. “Hypersomnolence” means excessive sleepiness or an unusually high need for sleep that is not explained by ordinary short sleep alone.

In KLS, symptoms occur in episodes. Diagnostic criteria generally require at least two recurrent episodes of excessive sleepiness and increased sleep duration, each lasting from 2 days to 5 weeks. Episodes usually recur more than once a year and at least once every 18 months. During episodes, hypersomnolence is accompanied by at least one additional feature, such as cognitive changes, altered perception, eating changes, or disinhibited behavior.

KLS is rare. It most often begins during adolescence and is reported more often in males, but it can affect people of any sex and can continue into adulthood. Adult-onset KLS is especially rare but can occur, and may be more likely to persist than adolescent-onset KLS.

KLS can be missed because symptoms overlap with other conditions. A person may appear depressed, intoxicated, confused, withdrawn, or behaviorally unlike themselves during an episode. Careful history from the affected person and from people who have seen the episodes is often essential.

KLS symptoms vary between people and may vary between episodes in the same person. 

During sleep and waking

A person may experience:

• Sleeping much more than usual – 12 to 20 hours per day
• Difficulty staying awake during daily tasks
• Waking briefly and returning quickly to sleep
• Sleep seems uncontrollable

Thinking, mood, and perception changes

During an episode, a person may have:

• Confusion or slowed thinking
• Difficulty concentrating, reading, working, or making decisions
• Memory gaps for parts of the episode
• Irritability, low mood, anxiety, or emotional flatness
• Derealization, meaning the world feels unreal, dreamlike, or distant
• Reduced motivation or marked apathy

Behavior and appetite changes

Some people also experience:

• Significant increase or decrease in appetite
• Childlike or unusually uninhibited behavior
• Hypersexual or socially inappropriate behavior
• Sensitivity to light, noise, or stimulation

During an episode, the whole 24 hours can become centered around an overwhelming need to sleep and a reduced ability to function when awake. Work, driving, household responsibilities, caregiving, relationships, meals, medications, and personal care may all be disrupted.

Adults may worry about when the next episode will happen, whether they can safely keep commitments, and how to explain a rare condition to employers, clinicians, friends, or family. Some people may feel embarrassed about behavior during episodes, especially if they were confused, irritable, or disinhibited.

There is no single blood test, brain scan, or sleep study that confirms KLS. Diagnosis is based on the pattern of symptoms and the exclusion of other causes. A primary care clinician can help begin evaluation, but KLS usually requires specialist input. A sleep medicine clinician, neurologist, psychiatrist, or hypersomnolence specialist may be involved depending on symptoms.

A clinician may ask about:

• Episode timing, frequency, duration, and triggers
• Sleep duration during and between episodes
• Changes in thinking, mood, perception, eating, or behavior
• Substance use, medications, infections, head injury, migraine, seizures, or psychiatric symptoms
• Family observations during episodes
• Whether the person returns to baseline between episodes

Tools and tests may include:

• A sleep diary or episode diary
• Actigraphy to record rest and activity patterns
• Polysomnography, or an overnight sleep study, when another sleep disorder is suspected
• Multiple sleep latency testing in selected cases
• Neurological examination
• Blood tests, toxicology testing, brain imaging, or EEG when clinically indicated

When to talk with a healthcare professional

A person does not need to know the name or exact nature of a condition before asking for help. If a person experiences any of the symptoms above, it is appropriate to discuss them with a healthcare professional. 

Red Flag: Seek urgent medical care if symptoms or sleep loss are affecting a person’s ability to drive or work safely, or is causing severe distress or thoughts of self-harm.

What to bring to a doctor’s visit

A primary care physician is a good place to start for a sleep disorder evaluation. They can conduct preliminary screenings and recommend next steps for diagnosis. It can be helpful to bring information to an initial visit: try using WSCN’s How to talk to your primary care clinician about sleep problems checklist.

Causes and risk factors

The exact cause of KLS is not known. Research suggests that immune, inflammatory, genetic, neurochemical, and brain-network factors may be involved, but no single cause explains all cases.

Possible contributors or associations include:

• Onset after infection or flu-like illness in some people
• Genetic susceptibility in a subset of people
• Hypothalamic, thalamic, or frontotemporal (brain) network involvement
• Menstrual-related hypersomnia

Triggers for KLS episodes vary. Some people report episodes after infection, sleep deprivation, alcohol use, stress, travel, head injury, or menstruation, but these patterns are not universal.

Long-term health implications

KLS is episodic, but unmanaged episodes can have important health and safety consequences:

• Safety risk: Severe sleepiness and confusion can increase risk during driving, cooking, machinery use, caregiving, or leaving home alone.
• Mental health: Uncertainty, stigma, loss of control, and behavior changes during episodes may contribute to anxiety, low mood, isolation, or distress.
• Work and financial strain: Recurrent episodes may disrupt employment, education, income, and independence without accommodations.
• Nutrition and metabolic patterns: Episode-related appetite changes, inactivity, and disrupted routines may affect weight, digestion, or metabolic health for some people.
• Medication and care disruption: Long sleep periods and confusion can interfere with regular medications, hydration, medical appointments, and chronic-condition care.
• Relationships and quality of life: Episodes may affect communication, intimacy, caregiving roles, and family routines.

These risks do not mean that KLS inevitably causes long-term health problems, just that safety planning and support are part of care.

There is no cure for KLS. Treatment and management approaches are individualized and depend on episode severity and symptoms. 

Management goals include:

• Protecting safety during episodes
• Reducing distress and confusion
• Preserving hydration, nutrition, and medication routines
• Planning for work, school, and family accommodations
• Considering medication when benefits may outweigh risks
• Reassessing if the pattern changes

During episodes, supportive care is central. A quiet, safe environment, reduced demands, and supervision may be the most important steps.

Medications may be considered in some cases. Stimulants or wake-promoting medications may reduce sleepiness for some people but often do not fully improve confusion or altered perception during episodes. Lithium has been studied as a preventive option and may reduce episode frequency or duration in selected patients, but it requires careful monitoring and is not appropriate for everyone. Other medications have been reported in small studies or case reports, but evidence remains limited.

Treatment should also address other conditions that can worsen sleepiness or complicate diagnosis, such as obstructive sleep apnea, depression, anxiety, seizures, medication effects, or substance use.

Living With Kleine-Levin Syndrome

Living with KLS often requires planning for unpredictability. A written episode plan can help the person and their support network respond consistently.

Useful steps include:

• Keep an episode diary with start date, end date, sleep duration, symptoms, possible triggers, and recovery time
• Identify one or two trusted support people who can help with care
• Create a no-driving plan
• Prepare a medication, hydration, and meal checklist
• Share a brief medical summary with emergency contacts
• Discuss workplace accommodations before a crisis occurs
• Plan how to communicate absences 

Between episodes, people may benefit from regular sleep timing, protection against sleep deprivation, stress management, and follow-up with a clinician familiar with hypersomnolence disorders. These steps may not prevent KLS, but they can support overall 24-hour health and reduce avoidable risks.

KLS research is challenging because the condition is rare, episodes are unpredictable, and many studies involve small groups. Researchers are studying genetics, immune triggers, brain imaging, biomarkers, and better treatment options.

Recent research has explored genetic associations, and has suggested overlap with pathways involved in mood regulation and neurodevelopment. Other studies continue to examine lithium and other preventive approaches, but larger controlled studies are still needed.

Important unanswered questions include why episodes start and stop, why some people recover over time while others continue to have episodes into adulthood, which treatments work best for which patients, and how to support people during long symptom-free intervals.